[1]
|
Ellis, H., Moran, B.J., Thompson, J.N., Parker, M.S., Wilson, M.S. et al. (1999) Adhesion-related hospital readmissions after abdominal and pelvic surgery: A retrospective cohort study. Lancet, 353, 1476-1480.
doi:10.1016/S0140-6736(98)09337-4
|
[2]
|
Menzies, D. and Ellis, H. (1990) Intestinal obstruction from adhesions--how big is the problem? Annals of The Royal College of Surgeons of England, 72, 60-63.
|
[3]
|
Tingstedt, B., Andersson, E., Isaksson, K. and Andersson, R. (2008) Clinical impact of abdominal adhesions: What is the magnitude of the problem? Scandinavian Journal of Gastroenterology, 43, 255-261.
doi:10.1080/00365520701708626
|
[4]
|
Tingstedt, B., Isaksson, J. and Andersson, R. (2007) Long-term follow-up and cost analysis following surgery for small bowel obstruction caused by intra-abdominal adhesions. British Journal of Surgery, 94, 743-748.
doi:10.1002/bjs.5634
|
[5]
|
Tingstedt, B., Isaksson, K., Andersson, E. and Andersson, R. (2007) Prevention of abdominal adhesions--present state and what’s beyond the horizon? European Surgical Research, 39, 259- 268. doi:10.1159/000102591
|
[6]
|
Johns, D.B., Rodgers, K.E., Donahue, W.D., Kiorpes, T.C. and diZerega, G.S. (1997) Reduction of adhesion formation by post-operative administration of ionically cross-linked hyaluronic acid. Fertility and Sterility, 68, 37-42. doi:10.1016/S0015-0282(97)81472-0
|
[7]
|
diZerega, G.S., Verco, S.J., Young, P., Kettel, M., Kobak, W.A., Martin, D. et al. (2002) A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery. Human Reproduction, 17, 1031-1038. doi:10.1093/humrep/17.4.1031
|
[8]
|
Muller, S.A., Treutner, K.H., Tietze, L., Anurov, M., Titkova, S., Polivoda, M. et al. (2001) Efficacy of adhesion prevention and impact on wound healing of intraperitoneal phospholipids. Journal of Surgical Research, 96, 68-74. doi:10.1006/jsre.2000.6031
|
[9]
|
Nehez, L., Tingstedt, B., Vodros, D., Axelsson, J., Lindman, B. and Andersson, R. (2006) Novel treatment in peritoneal adhesion prevention: protection by polypeptides. Scandinavian Journal of Gastroenterology, 41, 1110-1117. doi:10.1080/00365520600554550
|
[10]
|
Tingstedt, B., Nehez, L., Axelsson, J., Lindman, B. and Andersson, R. (2006) Increasing anastomosis safety and preventing abdominal adhesion formation by the use of polypeptides in the rat. International Journal of Colorectal Disease, 21, 566-572.
doi:10.1007/s00384-005-0053-x
|
[11]
|
Tingstedt, B., Nehez, L., Lindman, B. and Andersson, R. (2007) Efficacy of bioactive polypeptides on bleeding and intra-abdominal adhesions. European Surgical Research, 39, 35-40. doi:10.1159/000098438
|
[12]
|
Nehez, L., Vodros, D., Axelsson, J., Tingstedt, B., Lindman, B. and Andersson, R. (2005) Prevention of postoperative peritoneal adhesions: Effects of lysozyme, polylysine and polyglutamate versus hyaluronic acid. Scandinavian Journal of Gastroenterology, 40, 1118-1123.
doi:10.1080/00365520510023332
|
[13]
|
Isaksson, K., ?kerberg, D., Andersson, R. and Tingstedt, B. (2009) Toxicity and dose response of intra-abdominally administered poly-L-alpha-lysine and poly-L-glutamate for post-operative adhesion protection. European Surgical Research, 44, 17-22. doi:10.1159/000258654
|
[14]
|
Holmdahl, L., Al-Jabreen, M. and Risberg, B. (1994) Experimental models for quantative studies on adhesion formation in rats and rabbits. European Journal of Surgery, 26, 248-56. doi:10.1159/000129342
|
[15]
|
King, A., Strand, B., Rokstad, A.M., Kulseng, B., Andersson, A. et al. (2003) Improvement of the biocompatibility of alginate/poly-L-lysine/alginate microcapsules by the use of epimerized alginate as a coating. Journal of Biomedical Materials Research A, 64, 533-539. doi:10.1002/jbm.a.10276
|
[16]
|
Takei, Y., Maruyama, A., Ferdous, A., Nishimura, Y., Kawano, S., Ikeijima, K. et al. (2004) Targeted gene delivery to sinusoidal endothelial cells: DNA nanoassociate bearing hyaluronanglycocalyx. The FASEB Journal, 18, 699-701.
|
[17]
|
Geornaras, I., Yoon, Y., Belk, K.E., Smith, G.C. and Sofos, J.N. (2007) Antimicrobial activity of epsilon-polylysine against Escherichia coli O157:H7, Salmonella Typhimurium, and Listeria monocytogenes in various food extracts. Journal of Food Science, 72, M330-334. doi:10.1111/j.1750-3841.2007.00510.x
|
[18]
|
Billinger, M., Buddeberg, F., Hubbell, J.A., Elbert, D.L., Schaffner, T., Mettler, D. et al. (2006) Polymer stent coating for prevention of neointimal hyperplasia. Journal of Invasive Cardiology, 18, 423-426.
|
[19]
|
Li, C., Yu, D.F., Newman, R.A., Cabral, F., Stephens, L.C., Hunter, N. et al. (1998) Complete regression of well-established tumors using a novel water-soluble poly-(L-glutamic acid)-paclitaxel conjugate. Cancer Research, 58, 2404-2409.
|
[20]
|
Moroson, H. (1971) Polycation-treated tumor cells in vivo and in vitro. Cancer Research, 31, 373-380.
|
[21]
|
Shih, I.L., Van, Y.T. and Shen, M.H. (2004) Biomedical applications of chemically and microbiologically synthesized poly (glutamic acid) and poly(lysine). Mini Reviews in Medicinal Chemistry, 4, 179-188.
doi:10.2174/1389557043487420
|
[22]
|
Larsson, K. (1994) Lipids-molecular organizations, physical functions and technical applications. The Oily Press, Dundee, Scotland.
|
[23]
|
Tingstedt, B., Nehez, L., Lindman, B. and Andersson, R. (2007) Effect of bioactive polypeptides on leaking large bowel anastomosis and intestines in the rat. Journal of Investigative Surgery, 20, 229-235.
doi:10.1080/08941930701481288
|
[24]
|
Morgan, D.M., Larvin, V.L. and Pearson, J.D. (1989) Biochemical characterisation of polycation-induced cytotoxicity to human vascular endothelial cells. Journal of Cell Science, 94, 553-559.
|
[25]
|
Moreau, E., Domurado, M., Chapon, P., Vert, M. and Domurad, D. (2002) Biocompatibility of polycations: In vitro agglutination and lysis of red blood cells and in vivo toxicity. Journal of Drug Targeting, 10, 161-173.
doi:10.1080/10611860290016766
|
[26]
|
Sela, M. and Katchalski, E. (1959) Biological properties of poly-alpha-amino acids. Advances in Protein Chemistry, 14, 391-478.
doi:10.1016/S0065-3233(08)60614-2
|
[27]
|
Kenausis, G., Voros, J., Elbert, D., Huang, N., Hofer, R., Riuz-Taylor, L. et al. (2000) Poly(l-lysine)-g-Poly-(ethy- lene glycol) layers on metal oxide surfaces: Attachment mechanism and effects of polymer architecture on resistance to protein adsorption. The Journal of Physical Chemistry B, 104, 3298- 3309. doi:10.1021/jp993359m
|
[28]
|
Andrews, D.W. and Ottensmeyer, F.P. (1982) Electron microscopy of the poly-L-lysine alpha-helix. Ultramicro- scopy, 9, 337-348. doi:10.1016/0304-3991(82)90094-8
|
[29]
|
Chittchang, M., Salamat-Miller, N., Alur, H.H., VanderVelde, D.G., Mitra, A.K. and Johnston, T.P. (2002) Poly(L-lysine) as a model drug macromolecule with which to investigate secondary structure and membrane transport, part I: Physicochemical and stability studies. Journal of Pharmacy and Pharmacology, 54, 315-323.
doi:10.1211/0022357021778556
|
[30]
|
Fischer, D., Li. Y., Ahlemeyer, B., Kriegelstein, J. and Kissel, T. (2003) In vitro cytotoxicity testing of polycations: Influence of polymer structure on cell viability and hemolysis. Biomaterials, 24, 1121-1131.
doi:10.1016/S0142-9612(02)00445-3
|
[31]
|
Lv, H., Zhang, S., Wang, B., Cui, S. and Yan, J. (2006) Toxicity of cationic lipids and cationic polymers in gene delivery. Journal of Controlled Release, 114, 100-109.
doi:10.1016/j.jconrel.2006.04.014
|
[32]
|
Shih, I.L., Shen, M.H. and Van, Y.T. (2004) Microbial synthesis of poly(ε-lysine) and its various applications. Bioresource Technology, 97, 1148-1159.
doi:10.1016/j.biortech.2004.08.012
|
[33]
|
Szende, B., Szokan, G., Tyiha, E., Pal, K., Gaborjanyi, R., Akmas, M. et al. (2002) Antitumor effect of lysine- isopeptides. Cancer Cell International, 2, 4.
doi:10.1186/1475-2867-2-4
|
[34]
|
Fuchs, S.M. and Raines, R.T. (2004) Pathway for polyarginine entry into mammalian cells. Biochemistry, 43, 2438-2444. doi:10.1021/bi035933x
|
[35]
|
Steijns, J.M. and van Hooijdonk, A.C. (2000) Occurrence, structure, biochemical properties and technological characteristics of lactoferrin. British Journal of Nutrition, 84, S11-17. doi:10.1017/S0007114500002191
|